Patent Application Titled "Alphavirus Vectors Containing Universal Cloning Adaptors" Published Online (USPTO 20240218395).

The patent application titled "Alphavirus Vectors Containing Universal Cloning Adaptors" discusses the development of immuno-therapeutics for the prevention and management of health conditions like cancer and microbial infection. The application focuses on nucleic acid constructs that contain a modified alphavirus genome or replicon RNA, with a synthetic adaptor molecule replacing a portion of the viral structural protein sequence. These constructs allow for the insertion of a different sequence and have potential applications in gene therapy, vaccine delivery, and drug delivery. The application provides detailed information about the constructs and their potential uses in gene therapy and viral research. [Extracted from the article]